+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

From
Protein Kinase C (PKC) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Protein Kinase C (PKC) Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Polo-Like Kinase Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Polo-Like Kinase Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
From
Cyclin-Dependent Kinase 2 (CDK2) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Cyclin-Dependent Kinase 2 (CDK2) Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Brutons Tyrosine Kinase (BTK) Inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Brutons Tyrosine Kinase (BTK) Inhibitors - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 100 Pages
  • Global
From
Bruton's Tyrosine Kinase (BTK) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Bruton's Tyrosine Kinase (BTK) Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
MAP kinase kinase 1 inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

MAP kinase kinase 1 inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Histone Deacetylase 6 - Pipeline Insight, 2024 - Product Thumbnail Image

Histone Deacetylase 6 - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
C-Raf Kinase Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

C-Raf Kinase Inhibitor - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Fms-like tyrosine kinase 3 inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Fms-like tyrosine kinase 3 inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 70 Pages
  • Global
From
Spleen Tyrosine Kinase (SYK) Inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Spleen Tyrosine Kinase (SYK) Inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
DNA gyrase inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

DNA gyrase inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Mayus Kinase 1 (JAK1) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Mayus Kinase 1 (JAK1) Inhibitor - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 90 Pages
  • Global
From
Matrix Metalloproteinase 9 (MMP-9) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Matrix Metalloproteinase 9 (MMP-9) Inhibitor - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Checkpoint kinase inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Checkpoint kinase inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 90 Pages
  • Global
From
Cathepsin S inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Cathepsin S inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
TYK2 kinase inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

TYK2 kinase inhibitors - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Aurora-A kinase inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Aurora-A kinase inhibitors - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more